Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun;16(6):392-400.
doi: 10.1038/nri.2016.43. Epub 2016 May 9.

Harnessing the beneficial heterologous effects of vaccination

Helen S Goodridge  1 , S Sohail Ahmed  2 , Nigel Curtis  3 , Tobias R Kollmann  4 , Ofer Levy  5 , Mihai G Netea  6 , Andrew J Pollard  7 , Reinout van Crevel  6 , Christopher B Wilson  8
Affiliations
Review

Harnessing the beneficial heterologous effects of vaccination

Helen S Goodridge et al. Nat Rev Immunol. 2016 Jun.

Abstract

Clinical evidence strongly suggests that certain live vaccines, in particular bacille Calmette-Guérin (BCG) and measles vaccines, can reduce all-cause mortality, most probably through protection against non-targeted pathogens in addition to the targeted pathogen. The underlying mechanisms are currently unknown. We discuss how heterologous lymphocyte activation and innate immune memory could promote protection beyond the intended target pathogen and consider how vaccinologists could leverage heterologous immunity to improve outcomes in vulnerable populations, in particular the very young and the elderly.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Heterologous lymphocyte responses
a | Some heterologous effects may be attributed to antigen-specific mechanisms that generate lymphocytes whose antigen receptors are cross-reactive for distinct microbial or host antigens due to molecular mimicry. Alternatively, a vaccine may induce bystander activation of memory lymphocytes to sustain levels of antibodies directed against other targets. b | Heterologous lymphocyte responses can induce protection against unrelated pathogens via antigen-specific bystander lymphocytes or induction of antigen non-specific innate mechanisms such as cytokine production to activate macrophages.
Figure 2
Figure 2. Mechanisms of innate memory in monocytes and macrophages
Initial exposure of monocytes/macrophages or their progenitors to certain microbial stimuli induces epigenetic marks and metabolic changes that persist for extended periods and influence the subsequent responses of these cells to the same or distinct stimuli. a | Priming/training increases the subsequent response, whereas tolerance reduces responsiveness. b | Priming/training and tolerance can occur simultaneously within the same cell, with expression of some genes being promoted and others suppressed. c | Innate memory effects may be long-lived due to the persistence of self-renewing macrophages in tissues, or exposed progenitors that continue to yield monocytes and macrophages with altered function for extended periods. Innate memory may be maintained indefinitely or wane over time.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dowling DJ, Levy O. Ontogeny of early life immunity. Trends Immunol. 2014;35:299–310. - PMC - PubMed
    1. Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity. 2010;33:492–503. - PMC - PubMed
    1. Khurana S, et al. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci Transl Med. 2011;3:85ra48. - PMC - PubMed
    1. Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348:694–9. - PMC - PubMed
    1. Aaby P, Kollmann TR, Benn CS. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol. 2014;15:895–9. - PubMed

Publication types